IRadimed Corp
NASDAQ:IRMD

Watchlist Manager

IRadimed Corp

NASDAQ:IRMD

Watchlist

Dividends

Price: 53.38 USD 1.19%

Market Cap: 676.3m USD

Have any thoughts about
IRadimed Corp?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US	Johnson & Johnson NYSE:JNJ	Pharmaceuticals
US	Berkshire Hathaway Inc NYSE:BRK.A	Financial Services
US	Bank of America Corp NYSE:BAC	Banking
US	Mastercard Inc NYSE:MA	Technology
US	UnitedHealth Group Inc NYSE:UNH	Health Care
US	Exxon Mobil Corp NYSE:XOM	Energy
US	Pfizer Inc NYSE:PFE	Pharmaceuticals
US	Palantir Technologies Inc NYSE:PLTR	Technology
US	Nike Inc NYSE:NKE	Textiles, Apparel & Luxury Goods
US	Visa Inc NYSE:V	Technology
CN	Alibaba Group Holding Ltd NYSE:BABA	Retail
US	3M Co NYSE:MMM	Industrial Conglomerates
US	JPMorgan Chase & Co NYSE:JPM	Banking
US	Coca-Cola Co NYSE:KO	Beverages
US	Walmart Inc NYSE:WMT	Retail
US	Verizon Communications Inc NYSE:VZ	Telecommunication

Add Price Alert

Price Target:

Last Price: 53.38 USD

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching

Delete

Cancel

IRMD Alert

IRadimed Corp

53.38

+0.63 (+1.19%)

52 Week Range	40.05 57.1909
Price Target

We'll email you a reminder when the closing price reaches USD.

Save Alert

Choose the stock you wish to monitor with a price alert.

	Johnson & Johnson NYSE:JNJ	US
	Berkshire Hathaway Inc NYSE:BRK.A	US
	Bank of America Corp NYSE:BAC	US
	Mastercard Inc NYSE:MA	US
	UnitedHealth Group Inc NYSE:UNH	US
	Exxon Mobil Corp NYSE:XOM	US
	Pfizer Inc NYSE:PFE	US
	Palantir Technologies Inc NYSE:PLTR	US
	Nike Inc NYSE:NKE	US
	Visa Inc NYSE:V	US
	Alibaba Group Holding Ltd NYSE:BABA	CN
	3M Co NYSE:MMM	US
	JPMorgan Chase & Co NYSE:JPM	US
	Coca-Cola Co NYSE:KO	US
	Walmart Inc NYSE:WMT	US
	Verizon Communications Inc NYSE:VZ	US

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

IRadimed Corp

What unique competitive advantages
does IRadimed Corp hold over its rivals?

What risks and challenges
does IRadimed Corp face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of IRadimed Corp.

What unique competitive advantages
does IRadimed Corp hold over its rivals?

What risks and challenges
does IRadimed Corp face in the near future?

Has there been any significant insider trading activity
in IRadimed Corp recently?

Summarize the latest earnings call
of IRadimed Corp.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for IRadimed Corp.

Provide P/S
for IRadimed Corp.

Provide P/E
for IRadimed Corp.

Provide P/OCF
for IRadimed Corp.

Provide P/FCFE
for IRadimed Corp.

Provide P/B
for IRadimed Corp.

Provide EV/S
for IRadimed Corp.

Provide EV/GP
for IRadimed Corp.

Provide EV/EBITDA
for IRadimed Corp.

Provide EV/EBIT
for IRadimed Corp.

Provide EV/OCF
for IRadimed Corp.

Provide EV/FCFF
for IRadimed Corp.

Provide EV/IC
for IRadimed Corp.

Show me price targets
for IRadimed Corp made by professional analysts.

What are the Revenue projections
for IRadimed Corp?

How accurate were the past Revenue estimates
for IRadimed Corp?

What are the Net Income projections
for IRadimed Corp?

How accurate were the past Net Income estimates
for IRadimed Corp?

What are the EPS projections
for IRadimed Corp?

How accurate were the past EPS estimates
for IRadimed Corp?

What are the EBIT projections
for IRadimed Corp?

How accurate were the past EBIT estimates
for IRadimed Corp?

Compare the revenue forecasts
for IRadimed Corp with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of IRadimed Corp and its key competitors using the latest financial data.

Compare historical revenue growth rates
of IRadimed Corp against its competitors.

Analyze the profit margins
(gross, operating, and net) of IRadimed Corp compared to its peers.

Compare the P/E ratios
of IRadimed Corp against its peers.

Discuss the investment returns and shareholder value creation
comparing IRadimed Corp with its peers.

Analyze the financial leverage
of IRadimed Corp compared to its main competitors.

Show all profitability ratios
for IRadimed Corp.

Provide ROE
for IRadimed Corp.

Provide ROA
for IRadimed Corp.

Provide ROIC
for IRadimed Corp.

Provide ROCE
for IRadimed Corp.

Provide Gross Margin
for IRadimed Corp.

Provide Operating Margin
for IRadimed Corp.

Provide Net Margin
for IRadimed Corp.

Provide FCF Margin
for IRadimed Corp.

Show all solvency ratios
for IRadimed Corp.

Provide D/E Ratio
for IRadimed Corp.

Provide D/A Ratio
for IRadimed Corp.

Provide Interest Coverage Ratio
for IRadimed Corp.

Provide Altman Z-Score Ratio
for IRadimed Corp.

Provide Quick Ratio
for IRadimed Corp.

Provide Current Ratio
for IRadimed Corp.

Provide Cash Ratio
for IRadimed Corp.

What is the historical Revenue growth
over the last 5 years for IRadimed Corp?

What is the historical Net Income growth
over the last 5 years for IRadimed Corp?

What is the current Free Cash Flow
of IRadimed Corp?

Discuss the annual earnings per share (EPS)
trend over the past five years for IRadimed Corp.

P/E
Price to Earnings

36.3

Current

Median

23.1

Industry

Higher than median

Higher than industry value

Price to Earnings (P/E) ratio is a valuation multiple that compares a company’s market capitalization to its net income. It indicates the dollar amount an investor can expect to invest in a company in order to receive $1 of that company’s earnings.

P/E

36.3

Market Cap

668.3m USD

Net Income

18.6m USD

All Countries

Forward Multiples

		Market Cap	P/E
US	IRadimed Corp NASDAQ:IRMD	668.3m USD	36.3
US	Abbott Laboratories NYSE:ABT	205.2B USD	35.6
US	Intuitive Surgical Inc NASDAQ:ISRG	193.1B USD	86.1
US	Stryker Corp NYSE:SYK	148.6B USD	41.4
US	Boston Scientific Corp NYSE:BSX	132.9B USD	74.1
IE	Medtronic PLC NYSE:MDT	109.9B USD	25.6
US	Becton Dickinson and Co NYSE:BDX	64.8B USD	37.6
DE	Siemens Healthineers AG XETRA:SHL	56.6B EUR	30.4
CN	Shenzhen Mindray Bio-Medical Electronics Co Ltd SZSE:300760	326.2B CNY	26.3
US	Edwards Lifesciences Corp NYSE:EW	42.2B USD	10.1
US	GE Healthcare Technologies Inc NASDAQ:GEHC	37.7B USD	22.5

			Earnings Growth
US	IRadimed Corp NASDAQ:IRMD	Average P/E: 38.7 36.3	62%
US	Abbott Laboratories NYSE:ABT	35.6	75%
US	Intuitive Surgical Inc NASDAQ:ISRG	86.1	86%
US	Stryker Corp NYSE:SYK	41.4	81%
US	Boston Scientific Corp NYSE:BSX	74.1	200%
IE	Medtronic PLC NYSE:MDT	25.6	123%
US	Becton Dickinson and Co NYSE:BDX	37.6	222%
DE	Siemens Healthineers AG XETRA:SHL	30.4	114%
CN	Shenzhen Mindray Bio-Medical Electronics Co Ltd SZSE:300760	26.3	66%
US	Edwards Lifesciences Corp NYSE:EW	10.1	21%
US	GE Healthcare Technologies Inc NASDAQ:GEHC	22.5	75%

P/E Forward Multiples

Forward P/E multiple is a version of the P/E ratio that uses forecasted net income for the P/E calculation. 1-Year, 2-Years, and 3-Years forwards use net income forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward

P/E

31.2

2-Years Forward

P/E

29.6

3-Years Forward

P/E

24.1

IRadimed Corp
NASDAQ:IRMD

P/E
Price to Earnings

P/E Forward Multiples

See Also

Company

Help

Tools

Stocks

IRadimed Corp NASDAQ:IRMD

P/E Price to Earnings

P/E Forward Multiples

See Also

Company

Help

Tools

Stocks

IRadimed Corp
NASDAQ:IRMD

P/E
Price to Earnings